• I asked the question had anyone got the frequency for the Artemis trip to the moon. (for those who don’t understand the question to hear comms from the space ship to NASA inflight to and from the moon)
    With the odd helpful reply i went on the hunt and found this info
    While you won’t be able to “tune in” with a standard handheld radio to hear the astronauts chatting, dedicated amateur radio operators with specialized equipment are actively preparing to track and receive signals from the Orion spacecraft.
    The primary communication for Artemis II happens on the S-band (2.2–2.3 GHz) and via a new high-speed Optical (laser) Communications System (O2O).
    • Public Access: You cannot hear them directly on standard VHF/UHF ham frequencies. However, many ham radio clubs (like those at NASA’s Johnson and Goddard Space Centers) often rebroadcast mission audio on local repeaters (e.g., 146.640 MHz in Houston or 147.450 MHz in Maryland) during major mission phases.
    • Encryption: Much of the modern voice and data telemetry is digital and encrypted for security and mission integrity, meaning even if you “catch” the signal, it would sound like white noise without a NASA-authorized decoder.
    • To participate, operators typically use large satellite dishes (often 1.2 meters to 4.5 meters or larger) and Software Defined Radios (SDRs) capable of receiving the S-band spectrum (specifically around 2210.5 MHz).
    • The Crew: Three of the four Artemis II astronauts—Reid Wiseman (KF5LKT)Victor Glover (KI5BKC), and Jeremy Hansen (KF5LKU).
    • If you have a 2.4 GHz dish and an SDR, you can try to “see” the signal spike on a waterfall display as Orion travels to the Moon. If you just want to hear the crew, your best bet is to listen to the NASA TV live stream or find a local ham repeater that is rebroadcasting the audio feed.
  • Clinical Trial Tests Cell Therapy to Cure People with Type 1 Diabetes
    7/14/2025 · Research
    Vertex is recruiting participants for its zimislecel (VX-880) cell therapy trial. Early study results show promise that zimislecel may be the first functional cure for type 1 diabetes.
    Trial status: Recruiting

    Clinical Trials Identifier: NCT04786262

    Trial name: A Safety, Tolerability, and Efficacy Study of VX-880 in Participants with Type 1 Diabetes Diabetes type: Adults 18-65 years of age with type 1 diabetes

    Trial sponsor: Vertex Pharmaceuticals

     

    This clinical trial is testing zimislecel (VX-880), the first fully differentiated cell-derived islet cell therapy for type 1 diabetes. Early study results so far are promising, with 12 participants no longer needing daily insulin after one year of therapy. Though immunosuppressants are required to prevent the body’s immune system from attacking and destroying the new cells (similar to when someone receives an organ transplant), research so far indicates that zimislecel could be the first functional cure for type 1 diabetes.

     

    This clinical trial is unique in that it’s a combination phase 1, 2, and 3 trial. That means participants are being recruited to receive the therapy for the first time, as well as following people who have been in the study for years to see how zimislecel is working longer term.

     

    You may be eligible to participate if you:

    • Are 18-65 years old Have been diagnosed with type 1 diabetes for at least five years
    • Have had at least two episodes of documented severe hypoglycemia in the past year
    • Are on a stable diabetes treatment plan
    • Have used a continuous glucose monitor (CGM) consistently for at least three months prior to screening for the trial, and are willing to use the CGM during the trial
    • Have not had any prior islet cell transplants, organ transplants, or cell therapy

     

    This trial is currently recruiting in 29 locations worldwide, including the U.S., Canada, France, Germany, the Netherlands, Norway, Switzerland, and more. Learn more about this study here or contact the Vertex study team at medicalinfo@vrtx.com or call (+)1-617-341-6777.

    https://diatribe.org/diabetes-research/clinical-trial-tests-cell-therapy-cure-people-type-1-diabetes